← Eichor
Study identifier: NCT05709132 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

iP2P Mentorship Program for Adolescent HF Patients

Condition: Heart Failure  ·  Sponsor: The Hospital for Sick Children

PhaseNA
Planned participants55
Who can joinAll sexes, 12 Years to 30 Years
Healthy volunteersNo

About this study

The iPeer2Peer (iP2P) program is an online peer support mentorship program that provides modelling and reinforcement by trained young adult peer mentors to adolescent mentees with the same condition. A quasi-experimental single-arm pre-post study design will be employed across three sites. We will recruit 40 mentees (12-17 years of age) and 12-15 mentors (18-30 years of age) who will undergo training in mentoring and the use of eHealth technology. Mentor-mentee pairings will connect over 15 weeks through video calls and text messaging to provide peer support and encourage disease self-management skills. Data will be collected using standardized instruments and interviews across three time points.

This description comes directly from the study's public registry record.

Talk to the study team

Samantha J Anthony, PhD  ·  416-813-7654  ·  samantha.anthony@sickkids.ca

Sophie Bui, BHSc  ·  sophie.bui@sickkids.ca

Always discuss trial participation with your own doctor first.

Locations (1)

The Hospital for Sick ChildrenToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05709132